-
-
-
-
-
-
-
Assertio and Garda postpone tender offer start to May 8, 2026
-
-
-
-
-
-
-
Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio
-
-
-
-
-
-
-
Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025
-
-
-
-
-
-
-
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO
-
-
-
-
-
-
-
Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024
-
-
-
-
-
-
-
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
BUXTON HELMSLEY RELEASES LETTER FROM CERTIFIED FRAUD EXAMINER ATTESTING TO DISCLOSURE FAILURES AND DEFICIENCIES BY ASSERTIO HOLDINGS BOARD OF DIRECTORS
-
1,160,143 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

